Nanocarriers may carry new hope for brain cancer therapy

Researchers have developed a new family of nanocarriers, called 3HM, that meets all the size and stability requirements for effectively delivering therapeutic drugs to the brain for the treatment of a deadly form of cancer known as glioblastoma multiforme.